Arcus Biosciences, Inc. (RCUS)

USD 7.85

(-0.13%)

Eps Summary of Arcus Biosciences, Inc.

  • Arcus Biosciences, Inc.'s latest annual eps in 2023 was -4.15 USD , down -11.86% from previous year.
  • Arcus Biosciences, Inc.'s latest quarterly eps in 2024 Q2 was -1.02 USD , down -2098.28% from previous quarter.
  • Arcus Biosciences, Inc. reported an annual eps of -3.71 USD in 2022, down -588.16% from previous year.
  • Arcus Biosciences, Inc. reported an annual eps of 0.76 USD in 2021, up 135.68% from previous year.
  • Arcus Biosciences, Inc. reported a quarterly eps of -0.05 USD for 2024 Q1, up 95.7% from previous quarter.
  • Arcus Biosciences, Inc. reported a quarterly eps of -1.02 USD for 2023 Q2, up 7.27% from previous quarter.

Annual Eps Chart of Arcus Biosciences, Inc. (2023 - 2016)

Historical Annual Eps of Arcus Biosciences, Inc. (2023 - 2016)

Year Eps Eps Growth
2023 -4.15 USD -11.86%
2022 -3.71 USD -588.16%
2021 0.76 USD 135.68%
2020 -2.13 USD -23.12%
2019 -1.73 USD -20.98%
2018 -1.43 USD -14.4%
2017 -1.25 USD -71.23%
2016 -0.73 USD 0.0%

Peer Eps Comparison of Arcus Biosciences, Inc.

Name Eps Eps Difference
ADC Therapeutics SA -2.94 USD -41.156%
Alto Neuroscience, Inc. -1.35 USD -207.407%
Annovis Bio, Inc. -6.23 USD 33.387%
Biohaven Pharmaceutical Holding Company Ltd. -5.73 USD 27.574%
Ginkgo Bioworks Holdings, Inc. -18.37 USD 77.409%
Nuvation Bio Inc. -0.35 USD -1085.714%
Nuvation Bio Inc. -0.35 USD -1085.714%
Zymeworks Inc. -1.72 USD -141.279%